HUP0300373A2 - Késleltetett leadású vitaminkészítmények és eljárás az előállításukra - Google Patents

Késleltetett leadású vitaminkészítmények és eljárás az előállításukra

Info

Publication number
HUP0300373A2
HUP0300373A2 HU0300373A HUP0300373A HUP0300373A2 HU P0300373 A2 HUP0300373 A2 HU P0300373A2 HU 0300373 A HU0300373 A HU 0300373A HU P0300373 A HUP0300373 A HU P0300373A HU P0300373 A2 HUP0300373 A2 HU P0300373A2
Authority
HU
Hungary
Prior art keywords
release
drug
inner core
preparation
sustained release
Prior art date
Application number
HU0300373A
Other languages
English (en)
Inventor
Jürgen Block
Stefan Heim
Ralf Westerheide
Original Assignee
Allphamed Pharbil Pharma Gmbh
Glaxosmithkline Consumer Healthcare Gmbh. & Co. Kg.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9888515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0300373(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Allphamed Pharbil Pharma Gmbh, Glaxosmithkline Consumer Healthcare Gmbh. & Co. Kg. filed Critical Allphamed Pharbil Pharma Gmbh
Publication of HUP0300373A2 publication Critical patent/HUP0300373A2/hu
Publication of HUP0300373A3 publication Critical patent/HUP0300373A3/hu
Publication of HU230771B1 publication Critical patent/HU230771B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)

Abstract

A találmány tárgya gyöngy formájában lévő, orális adagolásra alkalmasterápiás készítmény, amelyből a gyógyszer szabályozott sebességekkelszabadul fel, a gyöngy extrudált-szferonizált, legalább egy módosítottleadású gyógyszert tartalmazó belső magból, legalább egy azonnalileadású gyógyszert tartalmazó külső rétegből és egy gyógyászatilagelfogadható, szabályozott leadású, a belső mag és a külső réteg közöttelhelyezkedő bevonatból áll, amely bevonat szabályozza a belső magbélimódosított leadású gyógyszer felszabadulását. A találmány továbbitárgya több gyöngyöt tartalmazó orális dózisforma. A találmány mégtovábbi tárgya eljárás a találmány szerinti gyöngy előállítására. Ó
HU0300373A 2000-03-27 2001-03-21 Késleltetett leadású vitaminkészítmény HU230771B1 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB0007419.5A GB0007419D0 (en) 2000-03-27 2000-03-27 Composition
GB0007419.5 2000-03-27
PCT/EP2001/003192 WO2001072286A1 (en) 2000-03-27 2001-03-21 Sustained release vitamin composition

Publications (3)

Publication Number Publication Date
HUP0300373A2 true HUP0300373A2 (hu) 2003-06-28
HUP0300373A3 HUP0300373A3 (en) 2005-03-29
HU230771B1 HU230771B1 (hu) 2018-03-28

Family

ID=9888515

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0300373A HU230771B1 (hu) 2000-03-27 2001-03-21 Késleltetett leadású vitaminkészítmény

Country Status (15)

Country Link
US (1) US7422758B2 (hu)
EP (1) EP1267844B2 (hu)
KR (1) KR100824104B1 (hu)
AT (1) ATE381926T2 (hu)
AU (1) AU2001254711A1 (hu)
BR (1) BRPI0109575B8 (hu)
CZ (1) CZ304818B6 (hu)
DE (1) DE60132077T3 (hu)
ES (1) ES2298231T5 (hu)
GB (1) GB0007419D0 (hu)
HU (1) HU230771B1 (hu)
MX (1) MXPA02009547A (hu)
PL (1) PL202684B1 (hu)
RU (1) RU2248200C2 (hu)
WO (1) WO2001072286A1 (hu)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7560123B2 (en) 2004-08-12 2009-07-14 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US7985422B2 (en) 2002-08-05 2011-07-26 Torrent Pharmaceuticals Limited Dosage form
TWI319713B (en) * 2002-10-25 2010-01-21 Sustained-release tramadol formulations with 24-hour efficacy
US8487002B2 (en) * 2002-10-25 2013-07-16 Paladin Labs Inc. Controlled-release compositions
US8617617B2 (en) 2002-12-10 2013-12-31 Everett Laboratories, Inc. Methods and kits for co-administration of nutritional supplements
US6814983B2 (en) * 2002-12-10 2004-11-09 Everett Laboratories, Inc. Compositions and methods for nutrition supplementation
US20060172006A1 (en) * 2003-10-10 2006-08-03 Vincent Lenaerts Sustained-release tramadol formulations with 24-hour clinical efficacy
US20050226906A1 (en) * 2004-04-08 2005-10-13 Micro Nutrient, Llc Nutrient system for individualized responsive dosing regimens
US7785619B2 (en) * 2004-04-08 2010-08-31 Micro Nutrient, Llc Pharmanutrient composition(s) and system(s) for individualized, responsive dosing regimens
US8101587B2 (en) 2004-08-12 2012-01-24 Everett Laboratories, Inc. Kits for nutrition supplementation
DE102005011029A1 (de) * 2005-03-08 2006-09-14 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Zusammensetzung für die perorale Applikation mit gesteuerter Freisetzung von Wirkstoffen
GB0507167D0 (en) * 2005-04-08 2005-05-18 Glaxosmithkline Consumer Healt Composition
JP5269595B2 (ja) * 2005-09-09 2013-08-21 アンジェリーニ ラボファーム リミテッド ライアビリティ カンパニー １日１回投与用トラゾドン組成物
US20070128272A1 (en) * 2005-12-07 2007-06-07 Zerbe Horst G Multi-vitamin and mineral supplement
CA2882048C (en) 2006-02-03 2020-03-24 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
DK3357496T3 (da) 2006-06-21 2020-05-11 Opko Ireland Global Holdings Ltd Terapi ved brug af vitamin d-repletteringsmiddel og vitamin d-hormonsubstitutionsmiddel
US8491937B2 (en) * 2007-02-15 2013-07-23 Wyeth Llc Stability in vitamin and mineral supplements
CA2718571A1 (en) * 2007-03-12 2008-09-18 Pipex Pharmaceuticals, Inc. Oral zinc medicants useful for safely lowering free copper absorption and free copper levels
KR101495578B1 (ko) * 2007-04-25 2015-02-25 사이토크로마 인코포레이티드 비타민 ｄ 부족 및 결핍의 치료 방법
EP2148683A4 (en) 2007-04-25 2012-09-12 Proventiv Therapeutics Llc METHOD FOR THE SAFE AND EFFECTIVE TREATMENT AND PREVENTION OF SECONDARY HYPERPARATHYREOSIS IN CHRONIC KIDNEY DISEASE
ES2956794T3 (es) 2007-04-25 2023-12-28 Eirgen Pharma Ltd Liberación controlada de 25-hidroxivitamina D
DE102007027435A1 (de) * 2007-06-14 2008-12-18 X-Fab Semiconductor Foundries Ag Verfahren und Vorrichtung zur strukturierten Schichtabscheidung auf prozessierten Mikrosystemtechnikwafern
IL187159A0 (en) * 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
CN101815509A (zh) * 2007-08-03 2010-08-25 沙克利公司 营养剂量单位
US9763989B2 (en) 2007-08-03 2017-09-19 Shaklee Corporation Nutritional supplement system
US20090181084A1 (en) * 2008-01-15 2009-07-16 Ta-Ping Liao Oral fast-disintegrating tablet including particles of slowly-releaseable ascorbic acid
EP2281058B1 (en) 2008-04-02 2016-06-29 Opko Ireland Global Holdings, Ltd. Methods, compositions, uses, and kits useful for vitamin d deficiency and related disorders
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
NZ597319A (en) * 2009-06-25 2014-06-27 Alcobra Ltd A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
US8545892B2 (en) 2009-06-26 2013-10-01 Nano Pharmaceutical Laboratories, Llc Sustained release beads and suspensions including the same for sustained delivery of active ingredients
US20110091618A1 (en) * 2009-10-16 2011-04-21 Frito-Lay North America, Inc. Method for preventing oxidation and off flavors in high carotenoid foods
US20120301513A1 (en) * 2009-10-20 2012-11-29 Herbonis Ag Composition comprising solanum glaucophyllum for preventing and/or treating hypocalcaemia and for stabilizing blood calcium levels
EP3636280A1 (en) 2010-03-29 2020-04-15 Opko Ireland Global Holdings, Ltd. Methods and compositions for reducing parathyroid levels
US8183227B1 (en) 2011-07-07 2012-05-22 Chemo S. A. France Compositions, kits and methods for nutrition supplementation
US8168611B1 (en) 2011-09-29 2012-05-01 Chemo S.A. France Compositions, kits and methods for nutrition supplementation
DE102011122250A1 (de) 2011-10-24 2013-04-25 Maria Clementine Martin Klosterfrau Vertriebsgesellschaft Mbh Eisenhaltige Vitaminzusammensetzung
WO2014120730A2 (en) * 2013-01-29 2014-08-07 Otc Nutrition Llc Micronutrient fortification delivery
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
ES2785399T3 (es) * 2013-06-14 2020-10-06 Conaris Res Institute Ag Formulación de nicotinamida de liberación prolongada
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
KR20160050405A (ko) * 2014-10-29 2016-05-11 가톨릭대학교 산학협력단 지용성 첨가제와 약물을 포함하는 혈관용 약물 방출 풍선 및 이의 제조방법
CA2969860A1 (en) * 2015-01-07 2016-07-14 Corr-Jensen Inc. Compositions and methods for enhancing athletic performance
AU2015377223A1 (en) 2015-01-12 2017-08-31 Nano Pharmaceutical Laboratories Llc Layered sustained-release microbeads and methods of making the same
CA3013795A1 (en) * 2016-02-17 2017-08-24 Corr-Jensen Inc. Time release vitamins and minerals in edible oils
KR20180123100A (ko) 2016-03-28 2018-11-14 옵코 아일랜드 글로벌 홀딩스 리미티드 비타민 d 치료 방법
TW201739455A (zh) 2016-04-19 2017-11-16 菲林公司 菸鹼醯胺的口服醫藥組成物
WO2017185038A1 (en) 2016-04-22 2017-10-26 Receptor Life Sciences Fast-acting plant-based medicinal compounds and nutritional supplements
EA201892396A1 (ru) 2016-12-02 2019-04-30 Ресептор Лайф Сайенсиз, Инк. Быстродействующие растительные лекарственные соединения и биологически активные добавки
TR201702630A2 (tr) 2017-02-22 2018-09-21 Montero Gida Sanayi Ve Ticaret Anonim Sirketi Alfa li̇poi̇k asi̇t ve suda çözünür vi̇tami̇nler i̇çeren oral farmasöti̇k bi̇leşi̇mler
CN107375711B (zh) * 2017-08-25 2020-11-03 贵州盛茂白芨开发有限公司 一种白芨含片
DE202018101110U1 (de) 2018-02-28 2019-06-03 Omnivision Gmbh Einfach einzunehmende AREDS2-Medikation
EP3962463A1 (en) * 2019-04-30 2022-03-09 DSM IP Assets B.V. New delivery system for specific water-soluble vitamins
AR118962A1 (es) * 2019-05-22 2021-11-10 Bayer Consumer Care Ag Preparaciones de cápsulas de gelatina blanda de vitaminas y minerales que comprenden vitamina c en forma de una sal de ascorbato
US20220361552A1 (en) * 2019-12-10 2022-11-17 Tyler White Particles Containing a Lipid Matrix Core and Active Ingredient
TR202014936A2 (tr) 2020-09-21 2022-03-21 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Alfa li̇poi̇k asi̇t ve en az bi̇r b vi̇tami̇ni̇ i̇çeren bi̇r çi̇ft katmanli farmasöti̇k tablet
WO2023173111A2 (en) * 2022-03-11 2023-09-14 Balchem Corporation Intra-dosage form coatings and applications thereof
CN115569118B (zh) * 2022-10-27 2023-05-05 泓博元生命科技（深圳）有限公司 高效提升nad+水平的微球制剂及制备工艺

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB800973A (en) † 1954-08-13 1958-09-03 Sterling Drug Inc Improvements in or relating to pills or tablets
US2928770A (en) † 1958-11-28 1960-03-15 Frank M Bardani Sustained action pill
US3577512A (en) † 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
US3939259A (en) 1974-05-24 1976-02-17 Anthony Pescetti Coating composition and therapeutic preparation incorporating same
DE3403329A1 (de) † 1984-02-01 1985-08-01 Horst Dr. 4019 Monheim Zerbe Pharmazeutisches produkt in form von pellets mit kontinuierlicher, verzoegerter wirkstoffabgabe
EP0208362A1 (en) * 1985-06-28 1987-01-14 The Procter & Gamble Company Dietary supplements containing iron and enterically coated calcium
JPS62103012A (ja) * 1985-10-23 1987-05-13 Eisai Co Ltd 多重顆粒
AU591248B2 (en) † 1986-03-27 1989-11-30 Kinaform Technology, Inc. Sustained-release pharaceutical preparation
US4752479A (en) † 1986-05-27 1988-06-21 Ciba-Geigy Corporaton Multi vitamin and mineral dietary supplement with controlled release bioavailable iron
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
GB8711256D0 (en) * 1987-05-13 1987-06-17 Unilever Plc Protection
US5049394A (en) * 1987-09-11 1991-09-17 E. R. Squibb & Sons, Inc. Pharmaceutical composition containing high drug load and method for preparing same
JP2643222B2 (ja) * 1988-02-03 1997-08-20 エーザイ株式会社 多重層顆粒
US5026559A (en) † 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5158777A (en) * 1990-02-16 1992-10-27 E. R. Squibb & Sons, Inc. Captopril formulation providing increased duration of activity
DE4112464A1 (de) † 1991-04-17 1992-10-22 Henkel Kgaa Verbesserte retard-systeme fuer die zeitverzoegerte freigabe medizinischer und/oder biologischer wertstoffe aus einem depot-traegermaterial
GB9117361D0 (en) * 1991-08-12 1991-09-25 Euro Celtique Sa Oral dosage form
US5472712A (en) † 1991-12-24 1995-12-05 Euroceltique, S.A. Controlled-release formulations coated with aqueous dispersions of ethylcellulose
US5869084A (en) * 1994-06-20 1999-02-09 K-V Pharmaceuticals Co. Multi-vitamin and mineral supplements for women
DE19718012C1 (de) † 1997-04-29 1998-10-08 Jenapharm Gmbh Verfahren zur Herstellung peroral anwendbarer fester Arzneiformen mit gesteuerter Wirkstoffabgabe
JP3950175B2 (ja) * 1997-05-30 2007-07-25 オスモティカ・コーポレイション 多層浸透デバイス
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations

Also Published As

Publication number Publication date
WO2001072286A1 (en) 2001-10-04
ES2298231T5 (es) 2016-06-08
DE60132077T2 (de) 2008-12-18
HUP0300373A3 (en) 2005-03-29
BR0109575A (pt) 2003-04-15
CZ20023247A3 (cs) 2003-04-16
DE60132077D1 (de) 2008-02-07
RU2248200C2 (ru) 2005-03-20
EP1267844B1 (en) 2007-12-26
BRPI0109575B1 (pt) 2016-06-07
ES2298231T3 (es) 2008-05-16
US20030148992A1 (en) 2003-08-07
ATE381926T2 (de) 2008-01-15
EP1267844B2 (en) 2016-04-13
MXPA02009547A (es) 2004-07-30
KR100824104B1 (ko) 2008-04-21
AU2001254711A1 (en) 2001-10-08
HU230771B1 (hu) 2018-03-28
KR20030020267A (ko) 2003-03-08
PL202684B1 (pl) 2009-07-31
GB0007419D0 (en) 2000-05-17
DE60132077T3 (de) 2016-07-14
CZ304818B6 (cs) 2014-11-19
EP1267844A1 (en) 2003-01-02
PL359663A1 (en) 2004-08-23
BRPI0109575B8 (pt) 2021-05-25
US7422758B2 (en) 2008-09-09

Similar Documents

Publication Publication Date Title
HUP0300373A2 (hu) Késleltetett leadású vitaminkészítmények és eljárás az előállításukra
MY126555A (en) Oral pharmaceutical extended release dosage form
CA2339992C (en) Orally disintegrable tablet forming a viscous slurry
HK1107272A1 (en) Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane
ATE129406T1 (de) Rotogranulate und geschmacksabdeckende überzüge zur herstellung pharmazeutischer kautabletten.
KR101834033B1 (ko) 주의력 결핍 장애 치료용 고체 경구 제약 조성물
HUP0303695A2 (hu) Módosított hatóanyag-leadású metil-fenidát készítmények és eljárás az elõállításukra
AU1227899A (en) Osmotic medicament releasing system
HUP0002744A2 (hu) Gyors hatóanyag-leadású és ízmaszkírozó gyógyászati dózisforma
HUP0300722A2 (hu) Hidrogél segítségével szabályozott gyógyszerforma
HUP0301591A2 (hu) Szabályozott hatóanyag-leadású hidrokodon-készítmények
WO2003005968A3 (en) Dual release levodopa ethyl ester and decarboxylase inhibitor with immediate release levodopa
US9023389B1 (en) Compositions for treatment of attention deficit hyperactivity disorder
NO20071044L (no) Doseformer med enteraltbelagte tablettkjerner
ATE260645T1 (de) Agitationsunabhängige pharmazeutische multiple- unit-retardzubereitungen und verfahren zu ihrer herstellung
HUP9902878A2 (hu) Trimebutin-maleát filmtabletta
HRP20201722T1 (hr) Minitablete melatonina i postupak njihove proizvodnje
HU9301672D0 (en) Method for manufacturing solid dosing forms of medicaments with controlled releasing of active agents
HUP0301453A2 (hu) Eletriptánt tartalmazó, szigmoid görbe szerinti, szabályozott hatóanyag-leadású, szemcsés kompozíció és eljárás az előállítására
WO2009014372A3 (en) Dispersible tablet comprising coated drug-containing particles and method for the preparation thereof
HUP0204391A2 (en) The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
HUP0300970A2 (hu) Epinastint és pszeudoefedrint tartalmazó új gyógyszerkészítmények
CN113271929A (zh) 用于帮助睡眠的组合物及方法
EP1688131A1 (en) Orally disintegratable tablet forming a viscous slurry
HUP0500438A2 (hu) Egy opioidot szabályozott módon leadó, perorális beadásra alkalmas, fájdalomcsillapító hatású gyógyászati készítmény és eljárás előállítására

Legal Events

Date Code Title Description
FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

GB9A Succession in title

Owner name: ALLPHAMED PHARBIL PHARMA GMBH, DE

Free format text: FORMER OWNER(S): GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH. & CO. KG., DE

Owner name: OMEGA PHARMA NV, BE

Free format text: FORMER OWNER(S): GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH. & CO. KG., DE

FH91 Appointment of a representative

Free format text: FORMER REPRESENTATIVE(S): DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

Representative=s name: DANUBIA SZABADALMI ES JOGI IRODA KFT., HU

GB9A Succession in title

Owner name: OMEGA PHARMA INNOVATION & DEVELOPMENT NV, BE

Free format text: FORMER OWNER(S): ALLPHAMED PHARBIL PHARMA GMBH, DE; GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH. & CO. KG., DE; GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH. & CO. KG., DE; OMEGA PHARMA NV, BE

Owner name: ALLPHAMED PHARBIL PHARMA GMBH, DE

Free format text: FORMER OWNER(S): ALLPHAMED PHARBIL PHARMA GMBH, DE; GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH. & CO. KG., DE; GLAXOSMITHKLINE CONSUMER HEALTHCARE GMBH. & CO. KG., DE; OMEGA PHARMA NV, BE